Evoke Pharma
EVOK
EVOK was delisted on the 16th of December, 2025.
11 hedge funds and large institutions have $3.31M invested in Evoke Pharma in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
37% more capital invested
Capital invested by funds: $2.41M → $3.31M (+$899K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$337K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$30.7K |
| 3 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$27.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$18K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OM
1
Opaleye Management
Boston,
Massachusetts
| $1.73M | +$30.7K | +34 | +2% |
|
|
KCM
2
Knoll Capital Management
Miami,
Florida
| $380K | +$337K | +374 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $360K | +$17.1K | +19 | +6% |
|
|
CWG
4
C WorldWide Group
Copenhagen,
Denmark
| $318K | – | – | – |
|
5
California Public Employees Retirement System
Sacramento,
California
| $243K | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $129K | +$18K | +20 | +19% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $111K | – | – | – |
|
|
FANJ
8
Financial Architects (New Jersey)
Marlton,
New Jersey
| $30K | +$27.1K | +30 | New |
|
9
Morgan Stanley
New York
| $7K | – | – | – |
|
|
BIM
10
BlackRock Investment Management
Wilmington,
Delaware
| $3K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
|
12
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$2K | -3 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$2K | -3 | Closed |
|
EVOK Hedge Fund Activity: Q1 2015 in Review
11 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Evoke Pharma (EVOK) for Q1 2015, worth a combined $3.31M — up 37% from $2.41M a quarter earlier.
Fund positioning in EVOK was balanced in Q1 2015: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Knoll Capital Management, opening a new position worth an estimated $337K. The largest seller was Deutsche Bank, exiting entirely with an estimated $2K sold.
- 11 institutional investors held Evoke Pharma (EVOK) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $3.31M of Evoke Pharma stock for Q1 2015, up 37% quarter-over-quarter.
- 2 funds opened new Evoke Pharma positions in Q1 2015 and 2 closed out, a net change of 0 holders.
- The largest Evoke Pharma buyer in Q1 2015 was Knoll Capital Management, an estimated $337K added.
- The largest Evoke Pharma seller in Q1 2015 was Deutsche Bank, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2015.